---
title: "Weekly Recap | Carnival +1.88%, a bumpy week before Q3 earnings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300187422.md"
description: "Carnival (CCL) rose 1.88% this week to close at $22.25, ahead of the S&P 500’s 1.21% gain by about 0.67 percentage points. The move was bumpy: Monday (21 Sep) ended at $22.31, Tuesday (22 Sep) touched a weekly high of $23.35, then the stock faded to a low of $21.45 on Thursday (24 Sep) before settling at $22.25 on Friday (25 Sep). Full-week amplitude was 8.5%."
datetime: "2026-09-26T06:11:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300187422.md)
  - [en](https://longbridge.com/en/news/300187422.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300187422.md)
generator: "portal-rs"
---

# Weekly Recap | Carnival +1.88%, a bumpy week before Q3 earnings

## The Week

Carnival (CCL) rose 1.88% this week to close at $22.25, ahead of the S&P 500’s 1.21% gain by about 0.67 percentage points. The move was bumpy: Monday (21 Sep) ended at $22.31, Tuesday (22 Sep) touched a weekly high of $23.35, then the stock faded to a low of $21.45 on Thursday (24 Sep) before settling at $22.25 on Friday (25 Sep). Full-week amplitude was 8.5%.

## Key Events

The main company thread this week centred on product upgrades and pre-earnings repricing. On Tuesday, Holland America Line unveiled a new beach club and food pavilion at RelaxAway, Half Moon Cay, which coincided with a sharp intraday jump in Carnival shares. Oil also slid to an 11-day low, easing one input-cost concern for airlines and cruise operators. With Q3 results due on Monday, several brokers trimmed Carnival price targets this week, while Jefferies maintained its buy rating on Wednesday. Weekend Polymarket odds showed the market still divided on whether Carnival can beat earnings expectations on Monday.

## Analyst Ratings

Across 29 brokers covering the name, 18 rate it buy, 5 rate it overweight and 6 rate it hold, with no sell or underweight ratings. The consensus rating is buy, and the consensus target of $33.99 sits about 52.8% above the latest close. Targets range from $28.00 to $43.00, a wide spread that signals disagreement on the pace of profit recovery. Within the hotels, resorts and cruise lines industry, Carnival ranks 5th out of 30 peers by rating.

## The Week Ahead

Monday brings Carnival’s fiscal Q3 2026 earnings release, with consensus estimates at $1.3479 EPS and $8.391 billion revenue. The same day also sees the Dallas Fed manufacturing activity index. On Tuesday, the US releases FHFA house prices, the Case Shiller 20-city index, JOLTS job openings and consumer confidence, all of which could shape sentiment toward consumer and services exposure.

## In Short

Carnival had a volatile pre-earnings week: product news and cheaper oil lifted sentiment, but price-target cuts and low Polymarket odds for a beat pointed to caution ahead of Q3. The consensus target remains more than 50% above spot, while the latest session showed large-lot net selling against small-lot net buying, a gap between broker positioning and actual fund flow. Next week’s earnings print is the test.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [CCL.US](https://longbridge.com/en/quote/CCL.US.md)

## Related News & Research

- [AI’s $1 Trillion Funding Problem Is Moving From Stocks to Bonds](https://longbridge.com/en/news/300336501.md)
- [Micron or Nvidia: One AI Stock Is Poised to Outperform, the Other Is Harder to Call, Says Goldman Sachs](https://longbridge.com/en/news/300359724.md)
- [Nvidia’s CEO draws Pope Leo’s criticism as AI safety concerns surge 50%](https://longbridge.com/en/news/300379637.md)
- [SpaceX Stock Forecast: Valuation Is Hard to Justify, Says Top Investor](https://longbridge.com/en/news/300356131.md)
- [Micron has a chance to set the record straight with its earnings report](https://longbridge.com/en/news/300332751.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**